Helicobacter pylori vaccines: Lessons from small animal models

Scandinavian Journal of Immunology

Volumn 53, Issue 5, 2001, Pages 429-436

  Nedrud, J G ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELICOBACTER PYLORI VACCINE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL IMMUNITY; CELLULAR IMMUNITY; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICE;

EID: 0035035819     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2001.00912.x     Document Type: Review

References (87)

1. Attempt to fulfill Koch's postulate for pyloric Campylobacter
2. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH
3. Helicobacter pylori in peptic ulcer disease
4. Gastric cancer and lymphoma
5. Mechanisms of Helicobacter pylori infection: Bacterial factors
6. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell
7. Antibiotic treatment of helicobacter pylori infection
8. Characterization and therapy for experimental infection by Helicobacter mustelae in ferrets
9. Natural and experimental Helicobacter mustelae reinfection following successful antimicrobial eradication in ferrets
10. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys
11. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization
12. Immunisation against gastric infection with Helicobacter species: First step in the prophylaxis of gastric cancer?
13. H. pylori vaccines
14. Host response and vaccine development
15. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis
16. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection
17. Protection against Helicobacter pylori infection by intestinal immunisation with a 50/52-kDa subunit protein
18. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection
19. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems
20. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
21. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
22. Vaccination against helicobacter pylori in non-human primate models and humans
23. Successful immunization against gastric infection with Helicobacter species: Use of a cholera toxin B-subunit-wholecell vaccine
24. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against H
25. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection
26. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
27. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant
28. Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosylatransferase and Ig-binding activity
29. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4+ T cells
30. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly (D,L-lactide-co-glycolide) microparticles
31. Promotion of ulcerative duodenitis in young ferrets by oral immunization with Helicobacter mustelae and muramyl dipeptide
32. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B
33. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits
34. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers
35. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers
36. Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter felis infection in mice
37. Systemic immunizatin with urease protects mice against Heliocbacter pylori infection
38. Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice
39. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses
40. Systemic vaccination with the human adjuvant aluminum hydroxide induces protective type-2 cell-mediated immunity against Helicobacter pylori infection of the gastric mucosa
41. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori
42. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response
43. Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori
44. Suppressive effects of DNA vaccines encoding heat shock protein on helicobacter pylori-induced gastritis in mice
45. Quantitative and bioluminescent assay to measure efficacy of conventional and DNA vaccinations against Helicobacter pylori
46. Therapeutic immunization against Helicobacter infection
47. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice
48. Editorial: Therapeutic immunization against Helicobacter infection
49. Therapeutic immunization against Helicobacter mustelae infection in naturally infected ferrets
50. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection
51. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection
52. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies
53. H. pylori vaccine development in the post-genomic era: Can in silico translate to in vivo?
54. A Mr 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori
55. Immunization of Balb/c mice against Helicobacter felis infection with Helicobacter pylori urease
56. The groES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice
57. Development of a mouse model of Helicobacter pylori infection that mimics human disease
58. Catalase, a novel antigen for Helicobacter pylori vaccination
59. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor
60. Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice
61. Local and systemic antibody responses in humans with Helicobacter pylori infection
62. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects
63. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies
64. Isolation of recombinant protective Helicobacter pylori antigens
65. Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate
66. The complete genome sequence of the gastric pathogen Helicobacter pylori
67. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
68. Qualitative and quantitative analysis of the local and systemic antibody response in mice and humans with Helicobacter immunity and infection
69. Vaccine strategies for prevention of Helicobacter pylori infections
70. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice
71. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions
72. Murine CD4 T cell responses to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load
73. Helicobacter-specific cell-mediated immune responses display a predominant TH1 phenotype and promote a DTH response in the stomachs of mice
74. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice
75. Role of gamma interferon in helicobacter pylori-induced gastric inflammatory responses in a mouse model
76. Immunity against Helicobacter pylori: Significance of interleukin-4 receptor {alpha} chain status and gender of infected mice
77. Replication-defective adenovirus infection reduces helicobacter felis colonization in the mouse in a gamma interferon- and interleukin-12-dependent manner
78. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy
79. Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets
80. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis
81. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria
82. Vaccination of gnotobiotic piglets against Helicobacter pylori
83. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice
84. Urease-based mucosal immunization against Helicobacter heilmannii infection induces corpus atrophy in mice
85. Induction and maintenance of immune effector cells in the gastric tissue of mice orally immunized to Helicobacter pylori requires salivary glands
86. Cellular immune responses are essential for the development of Helicobacter felisassociated gastric pathology
87. Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice